In this episode on the future of healthcare, our partner Thilo Kaltenbach speaks with Prof. Dr. med. Harald HHW Schmidt about the rise of network pharmacology and its potential to transform pharmaceutical research and development. The conversation explores how moving beyond organ-based definitions of disease could enable a step change in treating root causes rather than symptoms.
What will this mean for pharma business models, clinical pathways, and the health systems of tomorrow?
For more information, visit our website at rolandberger.com.
Podden och tillhörande omslagsbild på den här sidan tillhör
Roland Berger. Innehållet i podden är skapat av Roland Berger och inte av,
eller tillsammans med, Poddtoppen.
